The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.

Detalles Bibliográficos
Publicado en:	Cancer (0008543X) Vol. 125; no. 10; pp. 1674 - 1683
Autores principales:	D'Adda, Mariella, Farina, Mirko, Schieppati, Francesca, Borlenghi, Erika, Bottelli, Chiara, Cerqui, Elisa, Ferrari, Samantha, Gramegna, Doriana, Pagani, Chiara, Passi, Angela, Maifredi, Adriana, Tucci, Alessandra, Capucci, Maria A., Ruggeri, Giuseppina, Rossi, Giuseppe
Formato:	Journal Article
Publicado:	Wiley-Blackwell May2019
Acceso en línea:	Ver este registro en EBSCOhost